DNB Health Care
Invest in a sector with stability, innovation, and global significance.
Health is one of the most stable and critical sectors in the global economy. Demand is driven by fundamental needs, regardless of economic cycles, and an increasing number of investors see the value of long-term exposure to the sector. DNB Health Care provides access to a broad and global universe of companies developing solutions for better, more efficient, and more accessible healthcare services.
The companies in the fund operate in a sector driven by structural megatrends such as an aging population, increasing lifestyle diseases, and heightened political prioritization of health investments. The fund invests across established and emerging areas within pharmaceuticals, biotechnology, medical devices, and healthcare services, with a clear focus on innovation and future treatment needs. At the same time, new technologies, such as artificial intelligence and automation, are being rapidly adopted in research, development, and patient treatment, creating attractive growth opportunities and potential for value creation in various market environments.
The actively managed equity fund typically invests in 30–50 companies across the subsectors of the healthcare sector. The fund seeks companies with good growth prospects, and an attractive valuation and risk profile.
The investment process is structured and fundamentally anchored, with a clear focus on valuation and risk management. The managers identify quality companies with sustainable competitive advantages and long-term value creation, and also include selective investments in mid-sized biotech companies based on DNB's own sector expertise.
Main investment areas: Pharmaceuticals, Biotechnology, Research technology and services, Diagnostics, Medical devices, Healthcare services and infrastructure, Health insurance, Digital health services.